Latest Articles
How Endometriosis Patients Can Change The World: Cat Bohannon On Healt - Endometriosis Foundation of America
How Endometriosis Patients Can Change The World: Cat Bohannon On Healt Endometriosis Foundation of America
Published: Feb. 27, 2026, 4:54 p.m.
Acrivon Therapeutics Conference Highlights ACR-368 Phase 2B Data, 52% ORR in Serous Endometrial Cancer - MarketBeat
Acrivon Therapeutics Conference Highlights ACR-368 Phase 2B Data, 52% ORR in Serous Endometrial Cancer MarketBeat
Published: Feb. 27, 2026, 4:50 p.m.
Acrivon Therapeutics Conference Highlights ACR-368 Phase 2B Data, 52% ORR in Serous Endometrial Cancer - Yahoo Finance
Acrivon Therapeutics Conference Highlights ACR-368 Phase 2B Data, 52% ORR in Serous Endometrial Cancer Yahoo Finance
Published: Feb. 27, 2026, 4:47 p.m.
ACRV: ACR-368 delivers strong efficacy and safety in serous endometrial cancer, advancing toward approval - TradingView
ACRV: ACR-368 delivers strong efficacy and safety in serous endometrial cancer, advancing toward approval TradingView
Published: Feb. 27, 2026, 3:34 p.m.
Danielle Collins Talks Health Battle And Retirement Visit The Up Coming Website (ufVLJO9Ewy) - Министерство иностранных дел Республики Беларусь
Danielle Collins Talks Health Battle And Retirement Visit The Up Coming Website (ufVLJO9Ewy) Министерство иностранных дел Республики Беларусь
Published: Feb. 27, 2026, 3:32 p.m.
Acrivon Highlights Promising ACR-368 Phase 2b Endometrial Data - TipRanks
Acrivon Highlights Promising ACR-368 Phase 2b Endometrial Data TipRanks
Published: Feb. 27, 2026, 3:24 p.m.
Advancing support for endometriosis and menstrual wellbeing - GOV.UK
Advancing support for endometriosis and menstrual wellbeing GOV.UK
Published: Feb. 27, 2026, 3:11 p.m.
Bindi Irwin Issues Desperate Plea After Emergency Health Scare - AOL.com
Bindi Irwin Issues Desperate Plea After Emergency Health Scare AOL.com
Published: Feb. 27, 2026, 3:08 p.m.
Get the iRobot Roomba 104 for $70 less at Amazon - Mashable
Get the iRobot Roomba 104 for $70 less at Amazon Mashable
Published: Feb. 27, 2026, 3 p.m.
ACRV: ACR-368 shows high efficacy and safety in serous endometrial cancer, supporting global expansion - TradingView
ACRV: ACR-368 shows high efficacy and safety in serous endometrial cancer, supporting global expansion TradingView
Published: Feb. 27, 2026, 2:50 p.m.
Link copied to clipboard!